INTERFERON BETA-1A

Search structure
Trade Names:
Synonyms:
Status: Approved (1996)
Entry Type: Protein
Molecule Category: UNKNOWN
ATC: L03AB07
UNII: XRO4566Q4R

Pharmacology

Action Mechanism of Action Reference
AGONIST Interferon alpha/beta receptor agonist PubMed FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Multiple Sclerosis, Relapsing-Remitting 3 D020529 ClinicalTrials
Respiratory Distress Syndrome 3 D012128 ClinicalTrials
Hepatitis C 3 D006526 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Colitis, Ulcerative 2 D003093 ClinicalTrials
Crohn Disease 2 D003424 ClinicalTrials
Alzheimer Disease 2 D000544 ClinicalTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 2 D020277 ClinicalTrials
Multiple Organ Failure 2 D009102 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Stroke 1 D020521 ClinicalTrials

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
18.24
Nervous system disorders
16.5
Injury, poisoning and procedural complications
9.43
Musculoskeletal and connective tissue disorders
8.45
Psychiatric disorders
7.37
Skin and subcutaneous tissue disorders
5.35
Vascular disorders
5.24
Infections and infestations
3.53
Gastrointestinal disorders
3.47
Respiratory, thoracic and mediastinal disorders
3.36
Investigations
2.73
Cardiac disorders
2.31
Immune system disorders
2.02

Cross References

Resources Reference
CAS NUMBER 145258-61-3
ChEMBL CHEMBL1201562
FDA SRS XRO4566Q4R
CONTENTS